Pulmonology
Latest News
Dupilumab moves forward as possible COPD treatment
Phase 3 data support dupilumab’s bid to become the first FDA-approved biologic for the treatment of COPD.
News
Tofacitinib may have possible protective effect against ILD in RA
“Most of the biologic therapies had similar rates of developing ILD, but the JAK inhibitor tofacitinib had a reduced risk,” said study first...
News
eNose knows S. aureus in children with cystic fibrosis
A cloud-connected electronic nose technology distinguished Staphylococcus aureus with an accuracy of 74%.
News
Exercise capacity and QOL linked to significant survival benefit with endobronchial valves
Independent of pulmonary function, improvement in exercise capacity and quality of life after lung volume reduction using endobronchial valves...
Commentary
COVID can mimic prostate cancer symptoms
“I had none of those previously reported experiences that could suddenly trigger a spike in PSA.”
News
Depression tied to inflammation and survival in lung cancer
A new study’s findings underscore the importance of assessing and treating depression in patients with cancer, particularly given the high rate of...
Commentary
What’s the ‘secret sauce’ to help patients move more?
When surveyed about aerobic exercise and strength training, only 24.6% meet weekly recommendations.
News
Liquid albuterol shortage effects reduced by alternative drugs, similar shortages may be increasingly common
The shortage of 0.5% albuterol sulfate inhalation solution gained increased attention earlier this month when Akorn Pharmaceuticals – one of just...
News
Brain imaging markers of breathlessness-expectation predict COPD rehabilitation success
D-cycloserine was associated with breathlessness improvement.
News
NOVIDs: Do some have the genes to dodge COVID?
Some in the U.S. have apparently managed to avoid the virus, data suggest.